Deutsche Bank Upgrades Colgate-Palmolive to Buy, Raises Price Target to $86
Deutsche Bank analyst Steve Powers upgrades Colgate-Palmolive (NYSE:CL) from Hold to Buy and raises the price target from $84 to $86.
Unusual Options Activity Insight: Colgate-Palmolive
Colgate-Palmolive (NYSE:CL) shares experienced unusual options activity on Monday. The stock price moved down to $79.41 following the option alert.
Colgate-Palmolive Shares Fall On Mixed Q2 Results, Rising Costs, Declining Profit Margins
Colgate-Palmolive Co (NYSE:CL) reported second-quarter FY21 sales growth of 9.5% year-on-year, to $4.26 billion, beating the analyst consensus of $4.24 billion. …
Colgate-Palmolive Q2 Base EPS $0.80, Inline, Sales $4.26B Beat $4.24B Estimate
Colgate-Palmolive (NYSE:CL) reported quarterly earnings of $0.80 per share which met the analyst consensus estimate. This is a 8.11 percent increase over earnings of $0.74 per share from the same period last year. The
Earnings Scheduled For July 30, 2021
Companies Reporting Before The Bell
• Lexicon Pharmaceuticals (NASDAQ:LXRX) is estimated to report earnings for its second quarter.
‘Watch for first real bottom (away from the pandemic stocks) from the drugs and consumer packaged goods. Look for Clorox/CL/PG’ -Tweet From CNBC’s Jim Cramer
https://twitter.com/jimcramer/status/1417211354293940232
Analyzing Colgate-Palmolive’s Ex-Dividend Date
On June 10, 2021, Colgate-Palmolive (NYSE:CL) announced shareholders can expect to receive a dividend payable on August 16, 2021. The stock will then go ex-dividend 1 business day(s) before the record date. Colgate-Palmolive has an ex-dividend date set for for July 20, 2021.
10 Most ‘Genius’ Marketing Campaigns Ever
The vast majority of marketing campaigns are, sadly, rather forgettable. Some are amusing or briefly distracting, a poor few are irritating or worse, but genius in marketing is the rarest of commodities.
UBS Initiates Coverage On Colgate-Palmolive with Buy Rating, Announces Price Target of $95
UBS analyst Peter Grom initiates coverage on Colgate-Palmolive (NYSE:CL) with a Buy rating and announces Price Target of $95.